Stockreport

Pliant Therapeutics Announces Appointment of David Pyott to Board of Directors

Pliant Therapeutics, Inc.  (PLRX) 
PDF SOUTH SAN FRANCISCO, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biopharmaceutical company focused on discover [Read more]